SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma

Carreno, G; Boult, JKR; Apps, JR; Gonzalez-Meljem, JM; Haston, S; Guiho, R; Stache, C; ... Martinez-Barbera, JP; + view all Carreno, G; Boult, JKR; Apps, JR; Gonzalez-Meljem, JM; Haston, S; Guiho, R; Stache, C; Danielson, LS; Koers, A; Smith, LS; Virasami, A; Panousopoulos, L; Buchfelder, M; Jacques, TS; Chesler, L; Robinson, S; Martinez-Barbera, JP; - view fewer (2019) SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma. Endocrine-Related Cancer , 26 (3) pp. 355-366. 10.1530/ERC-18-0538 . Green open access

http://bit.ly/2MYGfXH